COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
S. Sinha, V. Castillo, C. R. Espinoza, C. Tindle, A. G. Fonseca, J. M. Dan, G. D. Katkar, S. Das, D. Sahoo, P. Ghosh
This study identifies shared cellular and molecular features between severe COVID-19 and idiopathic pulmonary fibrosis, highlighting ER stress and AT2 cell dysfunction as key drivers.
bioRxiv · Nov 28, 2021Immunology